Article
Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
2021-04-09
Abstract excerpt
We tested human sera from large, demographically balanced cohorts of BNT162b2 vaccine recipients (n=51) and COVID-19 patients (n=44) for neutralizing antibodies against SARS-CoV-2 variants B.1.1.7 and B.1.351. Although the effect is more pronounced in the vaccine cohort, both B.1.1.7 and B.1.351 show significantly reduced levels of neutralization by vaccinated and convalescent sera. Age is negatively correlated wi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cc005c86-9047-5ee4-9455-64b1a95761e0
- DOI
- 10.1101/2021.04.04.21254881
